• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1370 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2023 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines and clinical pathways for management of acute lower GI bleeding
2023 Austrian Institute for Health Technology Assessment (AIHTA) [Update PET/PET-CT evidence for need based planning in the area of oncology]
2023 National Institute for Health and Care Excellence (NICE) AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images. NICE diagnostics guidance 55
2023 National Institute for Health and Care Excellence (NICE) FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care. NICE diagnostics guidance 48
2023 Penn Medicine Center for Evidence-based Practice (CEP) Embolization vs. conservative management for spontaneous abdominal or pelvic hemorrhage
2023 National Institute for Health and Care Excellence (NICE) Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers. NICE diagnostics guidance 52
2023 National Institute for Health and Care Excellence (NICE) MRI fusion biopsy systems for diagnosing prostate cancer. NICE diagnostics guidance 53
2023 National Institute for Health and Care Excellence (NICE) MRI-based technologies for assessing non-alcoholic fatty liver disease. NICE diagnostics guidance 50
2023 National Institute for Health and Care Excellence (NICE) Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option. NICE interventional procedures guidance 764
2023 National Institute for Health and Care Excellence (NICE) Endoscopic ultrasound-guided biliary drainage for biliary obstruction. NICE interventional procedures guidance 761
2023 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care ultrasound for guided central venous catheter insertion
2023 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Endobronchial ultrasonography in malignant and benign pulmonary pathology: linear and radial ultrasound-guided transbronchial needle aspiration: evaluation of safety, efficacy, and cost-effectiveness]
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report: V21-12A: Sonographic proof: Evidence report for the S3 guideline on abortion in the first trimester]
2023 WorkSafeBC Low intensity pulsed ultrasound (LIPUS) for preventing fractures
2023 Ontario Health Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts
2023 Agency for Care Effectiveness (ACE) HeartFlow FFRCT for the diagnosis of coronary artery disease
2023 Agency for Care Effectiveness (ACE) AcQMap for patients with cardiac arrhythmia
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: optimal use of echocardiography in Québec- diagnosis and follow-up of chronic heart failure]
2023 Austrian Institute for Health Technology Assessment (AIHTA) Transcranial magnetic resonance-guided high-intensity focused ultrasound treatment in patients with drug-resistant essential tremor
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on diagnosis and treatment of gout: test accuracy of various methods for diagnosing gout]
2023 Adelaide Health Technology Assessment (AHTA) Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours
2023 NIHR Health Technology Assessment programme Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023 Health Information and Quality Authority (HIQA) A slot-scanning, biplanar, digital X-ray imaging system for the evaluation and monitoring of orthopaedic conditions: evidence synthesis to support a generic justification decision
2023 Scottish Health Technologies Group (SHTG) Priorities for the north imaging alliance
2023 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Trends in utilisation of ultrasound by older Australians (2010-2019)
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Transient elastography in non-alcoholic fatty liver disease]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography angiography in vascular eye diseases]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Ultrasound therapy for scar tissue]
2022 Austrian Institute for Health Technology Assessment (AIHTA) [Risk-based breast cancer screening in Austria: a systematic analysis of predictive models to assess individual breast cancer risk, their utility and applicability in a breast cancer screening programme]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital breast tomosynthesis]
2022 NIHR Health Technology Assessment programme Improving the prediction of metastatic disease in primary colorectal cancer: Prospective multicentre evaluation of a prognostic model of conventional predictive variables and novel variables derived from perfusion computed tomography (Perfusion CT)
2022 Agency for Care Effectiveness (ACE) Caption guidance to guide image acquisition in point-of-care echocardiography for patients with cardiovascular disease
2022 Basque Office for Health Technology Assessment (OSTEBA) [Image-guided spinal fusion technology]
2022 Scottish Health Technologies Group (SHTG) A national radiology information system (RIS) for Scotland: perceived benefits and constraints to implementation
2022 NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022 WorkSafeBC Efficacy and/or effectiveness of treatments for lateral epicondylitis - barbotage and ultrasonic tenotomy
2022 NIHR Health Technology Assessment programme Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome: the RAPID-CTCA RCT
2022 Medical Services Advisory Committee (MSAC) Two testing options for determining eligibility for access to Pharmaceutical Benefits Schedule-subsidised aducanumab in patients with early stage Alzheimer disease
2022 NIHR Health Technology Assessment programme Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcervical radiofrequency ablation with intrauterine ultrasound guidance for uterine fibroids]
2022 Health Sciences Institute in Aragon (IACS) [Digital dermatoscopy]
2022 NIHR Health Technology Assessment programme Mammographic surveillance in breast cancer patients aged 50 years or older
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Low-intensity pulsed ultrasound for the treatment of pseudarthrosis]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Addendum to Commission "Low-intensity pulsed ultrasound for the treatment of pseudarthrosis"]
2022 NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: optimal use of cardiac ultrasound in Québec - diagnosing patients with a murmur and monitoring patients with valve diseases (native and prosthetic valves)]
2022 Agency for Care Effectiveness (ACE) Magnetic resonance image guided radiation therapy for patients with cancer
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Review of age limits in the mammography screening programme]
2022 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcervical radiofrequency ablation with intrauterine ultrasound guidance for uterine fibroids - Second addendum to commission H21-14]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [PSMA PET/CT staging in patients with prostate cancer biochemical recurrence]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Gated-SPECT in ischemic non-obstructive coronary artery disease (microvascular angina - INOCA)]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Fluorodopa PET scanning in Parkinson’s disease]
2021 Andalusian Health Technology Assessment Area (AETSA) [18F-FDG in myocardial viability for revascularization]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcranial magnetic resonance-guided focused ultrasound for the treatment of essential tremor - Assessment according to §137h Social Code Book V - Addendum to commission H20-05]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Prostate cancer; does the use of fusion biopsy lead to better treatment results compared to the use of conventional diagnostic procedures?]
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcranial magnetic resonance-guided focused ultrasound for the treatment of essential tremor - Assessment according to §137h Social Code Book V - Second addendum to commission H20-05]
2021 Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2021 Malaysian Health Technology Assessment (MaHTAS) Mobile C-arm fluoroscopy for cardiothoracic surgery
2021 Andalusian Health Technology Assessment Area (AETSA) [Laser interstitial thermal therapy for patients with refractory epilepsy: safety and effectiveness. A systematic review]
2021 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Radiation exposure by medical X-ray applications]
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Systematic review about effectiveness of digital pathology as a diagnostic tool for pathology and cytopathology]
2021 Agency for Care Effectiveness (ACE) MRI-US fusion targeted biopsy for diagnosis of prostate cancer
2021 NIHR Health Technology Assessment programme Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis
2021 National Institute for Health and Care Excellence (NICE) DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography. NICE medical technologies guidance 60
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Evidence report for the S3 guideline on dementia: Structural imaging]
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of using mpMRI for the diagnostic investigation of prostate cancer - mpMRI and prostate cancer diagnosis]
2021 National Institute for Health and Care Excellence (NICE) QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography. NICE diagnostics guidance 43
2021 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcranial magnetic resonance-guided focused ultrasound for the treatment of essential tremor - Assessment according to §137h Social Code Book V]
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Streamlining Medicare Benefits Schedule items for positron emission tomography (PET) project
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of single-photon emission computed tomography with [ 123I]ioflupane (DaTscan) in the diagnostic process for parkinsonian syndromes]
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: mammographic density and breast cancer screening]
2021 National Institute for Health and Care Excellence (NICE) Magnetic resonance therapy for knee osteoarthritis. NICE interventional procedures guidance 702
2021 National Institute for Health and Care Excellence (NICE) Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids. NICE interventional procedures guidance 689
2021 NIHR Health Technology Assessment programme Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation
2021 Health Technology Wales (HTW) Point-of-care ultrasound to diagnose gallstone disease
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) National spending and uptake of mobile radiology services in aged care facilities: an opportunity to improve access remains
2020 Penn Medicine Center for Evidence-based Practice (CEP) COVID-19: temperature screening for healthcare personnel
2020 HTA South [Exercise test in the investigation of suspected chronic coronary syndrome: a comparison with imaging and other functional tests]
2020 Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [CT or MRT diagnostics for suspected chronic coronary heart disease: an evidence mapping]
2020 The Regional Health Technology Assessment Centre (HTA-centrum) Magnetic resonance image-guided radiotherapy in patients with cancer in thorax, abdomen, pelvis or head and neck
2020 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Efficiency of 3D reconstruction in maxillofacial surgery]
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lung cancer screening using low-dose computed tomography]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Spyglass® cholangiopancreatoscopy for biliary and pancreatic diseases]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Fetal neurosonography in suspected central nervous system abnormalities]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Intravascular ultrasound in coronary artery disease]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital tomosynthesis for breast cancer]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Digital dermatoscopy for dysplastic nevi]
2020 Institute for Clinical Effectiveness and Health Policy (IECS) [Virtual colonoscopy for colorectal cancer screening in patients with diverticular disease]
2020 NIHR Health Technology Assessment programme Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
2020 Penn Medicine Center for Evidence-based Practice (CEP) Point of care vascular ultrasound
2020 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) PSMA PET/CT imaging for informing treatment of patients with prostate cancer
2020 NIHR Health Technology Assessment programme Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2020 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Technologies for the diagnosis of prostate cancer
2020 Scottish Health Technologies Group (SHTG) HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography
2020 Health Technology Wales (HTW) Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020 NIHR Health Technology Assessment programme Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
2020 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020 National Institute for Health and Care Excellence (NICE) MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy. NICE interventional procedures guidance 671